Bright Minds Biosciences Inc.
DRUG
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.74% | -3.73% | 850.34% | -6.39% | 3.24% |
| Total Receivables | 23.02% | 248.71% | 25.27% | 195.24% | -96.92% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 85.96% | 55.77% | 11.78% | 276.53% | 276.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -2.00% | -3.17% | 813.06% | -3.20% | -4.64% |
|
|
|||||
| Total Current Assets | -2.00% | -3.17% | 813.06% | -3.20% | -4.64% |
| Net Property, Plant & Equipment | -12.00% | -12.60% | 41.22% | 889.77% | -60.54% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -2.02% | -3.20% | 798.21% | -1.49% | -4.90% |
|
|
|||||
| Total Accounts Payable | -2.35% | 47.67% | -13.92% | 176.03% | -81.52% |
| Total Accrued Expenses | 85.71% | -40.57% | -65.70% | 180.91% | 48.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.91% | 7.13% | -14.12% | 476.47% | -60.16% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -0.05% | 38.34% | -18.02% | 199.85% | -79.11% |
|
|
|||||
| Total Current Liabilities | -0.05% | 38.34% | -18.02% | 199.85% | -79.11% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -25.40% | -19.22% | 161.09% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -3.16% | 27.28% | -5.54% | 222.30% | -79.11% |
|
|
|||||
| Common Stock & APIC | 5.41% | 1.09% | 135.95% | 2.40% | -1.06% |
| Retained Earnings | -20.22% | -8.71% | 6.24% | -3.64% | 1.73% |
| Treasury Stock & Other | 50.13% | -0.20% | -34.63% | -2.32% | 3.03% |
| Total Common Equity | -2.01% | -3.50% | 880.70% | -8.04% | 6.14% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.01% | -3.50% | 880.70% | -8.04% | 6.14% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.01% | -3.50% | 880.70% | -8.04% | 6.14% |
|
|
|||||